BRPI0813925A2 - Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição. - Google Patents

Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.

Info

Publication number
BRPI0813925A2
BRPI0813925A2 BRPI0813925-3A2A BRPI0813925A BRPI0813925A2 BR PI0813925 A2 BRPI0813925 A2 BR PI0813925A2 BR PI0813925 A BRPI0813925 A BR PI0813925A BR PI0813925 A2 BRPI0813925 A2 BR PI0813925A2
Authority
BR
Brazil
Prior art keywords
facilitating
aggestion
maillard
reversion
composition
Prior art date
Application number
BRPI0813925-3A2A
Other languages
English (en)
Inventor
Nabil Abdul-Malak
Cecile Altobelli
Eric Perrier
Original Assignee
Basf Beauty Care Solutions F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Beauty Care Solutions F filed Critical Basf Beauty Care Solutions F
Publication of BRPI0813925A2 publication Critical patent/BRPI0813925A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
BRPI0813925-3A2A 2007-07-09 2008-07-09 Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição. BRPI0813925A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756350A FR2918570B1 (fr) 2007-07-09 2007-07-09 DIGLYCATION DES AGEs.
PCT/EP2008/058955 WO2009007412A2 (fr) 2007-07-09 2008-07-09 Deglycation des ages

Publications (1)

Publication Number Publication Date
BRPI0813925A2 true BRPI0813925A2 (pt) 2014-12-30

Family

ID=39262794

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813925-3A2A BRPI0813925A2 (pt) 2007-07-09 2008-07-09 Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.

Country Status (8)

Country Link
US (1) US20100203175A1 (pt)
EP (1) EP2170358A2 (pt)
JP (2) JP2010533143A (pt)
KR (1) KR20100047253A (pt)
CN (2) CN103816095A (pt)
BR (1) BRPI0813925A2 (pt)
FR (2) FR2918570B1 (pt)
WO (1) WO2009007412A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928548B1 (fr) * 2008-03-14 2015-07-03 Basf Beauty Care Solutions F Substances augmentant le seuil d'activation des cellules immunes
JP2010077123A (ja) * 2008-08-29 2010-04-08 Hayashikane Sangyo Kk メイラード反応阻害剤
FR2951085B1 (fr) * 2009-10-09 2012-05-18 Inst Substances Vegetales Utilisation de composes phenoliques pour la deglycation des proteines
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
JP5878023B2 (ja) * 2010-02-10 2016-03-08 オリザ油化株式会社 Ａｇｅ産生抑制剤
JP6012138B2 (ja) * 2010-10-04 2016-10-25 小林製薬株式会社 抗糖化剤
JP5855492B2 (ja) * 2012-02-27 2016-02-09 三省製薬株式会社 ＡＧＥｓ産生抑制剤
JP6054700B2 (ja) * 2012-10-10 2016-12-27 株式会社ノエビア 脱糖化剤及び皮膚外用剤
JP2015096488A (ja) * 2013-10-10 2015-05-21 康二 嘉島 終末糖化物質生成抑制方法
CN105832724B (zh) * 2015-10-16 2018-07-03 北京冠瑞金生物科技有限公司 吲哚醇在制备抗抑郁症药物中的用途
JP2017088538A (ja) * 2015-11-10 2017-05-25 日本メナード化粧品株式会社 フィラグリン産生促進剤
KR102605628B1 (ko) * 2015-12-29 2023-11-22 주식회사 엘지생활건강 하스타토사이드를 포함하는 피부상태 개선용 조성물
CN110785161B (zh) * 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
JP2019214546A (ja) * 2018-06-11 2019-12-19 学校法人福岡大学 終末糖化産物生成抑制剤及び医薬組成物
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
CN109468370A (zh) * 2018-11-09 2019-03-15 广州益养生物科技有限公司 一种快速检测遗传性皮肤糖基化能力基因的方法
CN110684212A (zh) * 2019-10-31 2020-01-14 东南大学 一种仿贻贝的水下高粘性水凝胶的制备方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
CN112111020B (zh) * 2020-10-26 2022-07-19 无锡善元健康管理有限公司 桦树茸中抗糖成分的提取纯化及抗糖丸的制备方法
CN112370370B (zh) * 2020-11-19 2022-07-26 苏州禾研生物技术有限公司 一种氧糖双抗的组合物及其应用和氧糖双抗的产品
CN113876668B (zh) * 2021-11-16 2023-11-03 上海青颜博识生物技术有限公司 一种抗糖化植物来源组合物及其制备方法和在美容产品中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
JP2552297B2 (ja) * 1987-07-03 1996-11-06 ポーラ化成工業株式会社 美肌化粧料
FR2653336B1 (fr) * 1989-10-20 1994-04-08 Oreal Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
WO1993010756A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
JP3625501B2 (ja) * 1994-10-06 2005-03-02 御木本製薬株式会社 細胞賦活用皮膚外用剤原料の製造方法及び細胞賦活用皮膚外用剤
JPH08133940A (ja) * 1994-11-02 1996-05-28 Pola Chem Ind Inc 紫外線吸収剤及びこれを含有する化粧料
JPH0977655A (ja) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
FR2764190B1 (fr) * 1997-06-06 1999-10-15 Serobiologiques Lab Sa Produit cosmetique comprenant des extraits de plantes notamment a action depigmentante, antiradicalaire et anti-vieillissement
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
FR2787324B1 (fr) * 1998-12-21 2001-02-23 Serobiologiques Lab Sa Utilisation d'au moins un extrait d'une plante appartenant au genre cecropia et composition cosmetique ou dermopharmaceutique comportant un tel extrait
JP2000256259A (ja) * 1999-03-11 2000-09-19 Nippon Zoki Pharmaceut Co Ltd メイラード反応阻害剤
US6787566B2 (en) * 1999-04-05 2004-09-07 City Of Hope Breakers of advanced glycation endproducts
US6589944B1 (en) * 1999-04-05 2003-07-08 City Of Hope Breakers of advanced glycation endproducts
JP5209832B2 (ja) * 1999-04-05 2013-06-12 シティ・オブ・ホープ 後期糖化最終生成物（ａｇｅ）形成の新規阻害剤
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
WO2002085897A1 (en) * 2001-04-05 2002-10-31 Alangudi Sankaranarayanan Heterocyclic compounds for aging-related and diabetic vascular complications
EP1435930A2 (en) * 2001-10-15 2004-07-14 National Research Council Of Canada Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
HUP0104832A2 (en) * 2001-10-19 2003-08-28 Torrent Pharmaceuticals Ltd Cosmetic composition and method
KR20040038243A (ko) * 2002-10-31 2004-05-08 (주)마이코스메틱 생열귀나무 추출물을 함유하는 항산화 또는 항노화용 피부화장료 조성물
JP4247091B2 (ja) * 2002-10-31 2009-04-02 池田食研株式会社 皮膚老化防止剤
EP1437117A1 (de) * 2002-12-19 2004-07-14 Cognis France S.A. Verwendung von Sinapinsäure und/oder Sinapinsäurederivaten
EP1683805A4 (en) * 2003-10-24 2009-06-17 Meiji Seika Kaisha NEW ADVANCED GLYCATION TERMINAL PRODUCT FORMATION INHIBITOR AND ALDOSE REDUCTASE INHIBITOR
US20050137239A1 (en) * 2003-12-17 2005-06-23 Hines Michelle D. Thiazole derivatives
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品
US20070098824A1 (en) * 2005-10-27 2007-05-03 Kgk Synergize Inc. Canola extracts containing high levels of phenolic acids
WO2008073684A1 (en) * 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid

Also Published As

Publication number Publication date
JP2014028814A (ja) 2014-02-13
KR20100047253A (ko) 2010-05-07
CN101765432A (zh) 2010-06-30
FR2975495B1 (fr) 2017-06-09
FR2975495A1 (fr) 2012-11-23
JP2010533143A (ja) 2010-10-21
CN103816095A (zh) 2014-05-28
FR2918570B1 (fr) 2012-10-05
US20100203175A1 (en) 2010-08-12
EP2170358A2 (fr) 2010-04-07
WO2009007412A3 (fr) 2009-04-02
FR2918570A1 (fr) 2009-01-16
WO2009007412A2 (fr) 2009-01-15

Similar Documents

Publication Publication Date Title
BRPI0813925A2 (pt) Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.
BRPI0717219A2 (pt) "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica."
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
CR10733A (es) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
FI20051318A (fi) Selluloosapitoisen materiaalin käsittely ja siihen käytettäviä entsyymejä
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
DK2057153T3 (da) (3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin
DE502007005708D1 (de) 3 -amino- imidazo ä1,2-aüpyridinderivate mit sglt1 und sglt2 hemmender wirkung zur behandlung von diabetes vom typ 1 und typ 2
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
FR2888847B1 (fr) Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
BRPI1008727A2 (pt) derivados de azol substituídos, composição farmacêutica contendo os derivados, e método para o tratamento de doença de parkinson usando os mesmos
DK2247587T3 (da) 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepin-4-carboxylsyreamider og 2,3-dihydro-benzo[b]oxepin-4-carboxylsyreamider til behandling og forebyggelse af diabetes type 1 og 2
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
IL205350A0 (en) Novel 1, 3- dihydro - 5 - isobenzofurancarbonitrile derivatives and pharmacetical composition thereof for the treatment of premature ejaculation
ZA200706662B (en) Haloaryl substituted Aminopurines, compositions thereof, and methods of treatment therewith
FR2891825B1 (fr) Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0817332A2 (pt) Composição e método de ingrediente sensível estabilizado.
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
GB0809228D0 (en) Compounds inducing differentiation of myoblasts or muscle f bers into neuron cells,pharmaceutical composition including said compounds.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: G01N 33/68 (2006.01), A61K 8/34 (2006.01), A61K 8/